| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypertrophic Cardiomyopathy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiomyopathies | |||||
| Cardiomyopathy, Hypertrophic | |||||
| Hypertrophy | |||||
| 3 | More general conditions related to this trial | ||||
| Aortic Stenosis, Subvalvular | |||||
| Aortic Valve Stenosis | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Heart Valve Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| 4 | Interventions listed in this trial | ||||
| Diltiazem | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Verapamil | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Arrhythmia Agents | |||||
| Antihypertensive Agents | |||||
| Calcium Channel Blockers | |||||
| Cardiovascular Agents | |||||
| Membrane Transport Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| Brigham and Women's Hospital | |||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
| Children's Hospital Boston | |||||
|
